Changes in prescription practice of biological drugs in rheumatoid arthritis during the first three years of post-marketing use in Denmark and Norway: Criteria are becoming less stringent.

Elisabeth Hjardem; M.L. Hetland; Mikkel Østergaard; T.K. Kvien

Changes in prescription practice of biological drugs in rheumatoid arthritis during the first three years of post-marketing use in Denmark and Norway: Criteria are becoming less stringent.

Elisabeth Hjardem, M.L. Hetland, Mikkel Østergaard, T.K. Kvien

Original language	English
Publication date	2004
Publication status	Published - 2004

Cite this

@conference{a7b3bb9e62e249418f32d430ccb594a8,

title = "Changes in prescription practice of biological drugs in rheumatoid arthritis during the first three years of post-marketing use in Denmark and Norway: Criteria are becoming less stringent.",

author = "Elisabeth Hjardem and M.L. Hetland and Mikkel {\O}stergaard and T.K. Kvien",

year = "2004",

language = "English",

}